Skip to main content

Peer Review reports

From: The efficacy and safety of anti-CD19/CD20 chimeric antigen receptor- T cells immunotherapy in relapsed or refractory B-cell malignancies:a meta-analysis

Original Submission
9 Jul 2018 Submitted Original manuscript
25 Jul 2018 Author responded Author comments - Hui Zhou
Resubmission - Version 2
25 Jul 2018 Submitted Manuscript version 2
16 Aug 2018 Reviewed Reviewer Report - Olga Sukocheva
5 Sep 2018 Author responded Author comments - Hui Zhou
5 Sep 2018 Reviewed Reviewer Report - Vladislav Korobeynikov
Resubmission - Version 3
5 Sep 2018 Submitted Manuscript version 3
10 Sep 2018 Author responded Author comments - Hui Zhou
Resubmission - Version 4
10 Sep 2018 Submitted Manuscript version 4
Publishing
13 Sep 2018 Editorially accepted
26 Sep 2018 Article published 10.1186/s12885-018-4817-4

You can find further information about peer review here.

Back to article page